Infants exposed to TNF inhibitors in utero or through breast milk show no increased risk for severe infections or impaired ...

The results send a ‘clear, pragmatic message’ of IL-17 inhibition’s greater potency over IL-12/23 inhibition, an expert says.

Tumor necrosis factor inhibitors were not linked to additional weight gain in patients with psoriatic arthritis when age-related changes were considered.

The updated indication allows the use of Rinvoq prior to the use of tumor necrosis factor blocking agents in certain patients ...

J.K. Dobbins and RJ Harvey have been the straw to stir Denver’s drink, combining for 900 yards rushing, six rushing ...

The Phase 1 clinical trial is a randomized, double-blind, placebo-controlled study evaluating single and multiple ascending doses of FT2109 in healthy adult volunteers. The trial will assess the ...

NORTH CHICAGO - AbbVie (NYSE:ABBV), a prominent player in the biotechnology industry with a market capitalization of over $405 billion, announced Monday that its JAK inhibitor upadacitinib (RINVOQ) ...

INCHEON, South Korea, Oct. 17, 2025 /PRNewswire/ -- Celltrion, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved expanded indications for YUFLYMA® (adalimumab-aaty) ...

The probability of developing ocular EIMs was comparable across treatment classes among patients with HLA-B27-associated diseases.

CHICAGO -- Hitting rheumatoid arthritis (RA) early and hard, with targeted therapies as first-line treatment, appears to reduce the likelihood that it will reach the dreaded "difficult-to-treat" stage ...

The New England Patriots have officially ruled out four players for their Thursday Night Football matchup against the New ...